Selection of antigenically advanced variants of seasonal influenza viruses

Nature Microbiology

Volumn 1, Issue 6, 2016, Pages

  Li, Chengjun ^a   Hatta, Masato ^a   Burke, David F ^b,c   Ping, Jihui ^a   Zhang, Ying ^a   Ozawa, Makoto ^a,d   Taft, Andrew S ^a   Das, Subash C ^a   Hanson, Anthony P ^a   Song, Jiasheng ^a   Imai, Masaki ^a,e   Wilker, Peter R ^a   Watanabe, Tokiko ^f   Watanabe, Shinji ^f   Ito, Mutsumi ^d   Iwatsuki Horimoto, Kiyoko ^d   Russell, Colin A ^b,c,g   James, Sarah L ^b,c   Skepner, Eugene ^b,c   Maher, Eileen A ^a   Neumann, Gabriele ^a   Klimov, Alexander I ^h   Kelso, Anne ⁱ   McCauley, John ^j   Wang, Dayan ^k   Shu, Yuelong ^k   Odagiri, Takato ^l   Tashiro, Masato ^l   Xu, Xiyan ^h   Wentworth, David E ^h   Katz, Jacqueline M ^h   Cox, Nancy J ^h   Smith, Derek J ^b,c,m   Kawaoka, Yoshihiro ^a,d,f   more..

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF TOKYO   (Japan)

^e IWATE UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

ⁱ VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^j NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^k CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^l NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^m ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL; ANTIGENIC VARIATION; CHEMISTRY; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); MOLECULAR EVOLUTION; MOUSE; MUSTELA PUTORIUS FURO; ORTHOMYXOVIRUS INFECTION; SEASON;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENIC VARIATION; ANTIGENS, VIRAL; EVOLUTION, MOLECULAR; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE INFECTIONS; SEASONS;

EID: 84991384832     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.58     Document Type: Article

References (38)

1. Wright, P. F., Neumann, G. & Kawaoka, Y. in Fields Virology Vol. 2 (eds Knipe, D. M. et al.) Ch. 48, 1691-1740 (Wolters Kluwer, Lippincott Williams & Wilkins, 2007).
2. Hay, A. J., Gregory, V., Douglas, A. R. & Lin, Y. P. The evolution of human influenza viruses. Phil. Trans. R. Soc. Lond. B 356, 1861-1870 (2001).
3. Carrat, F. & Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852-6862 (2007).
4. Wang, T. T. et al. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathogens 6, e1000796 (2010).
5. Russell, C. A. et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26(Suppl 4), D31-D34 (2008).
6. Belongia, E. A. et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J. Infect. Dis. 199, 159-167 (2009).
7. De Jong, J. C., Beyer, W. E., Palache, A. M., Rimmelzwaan, G. F. & Osterhaus, A. D. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J. Med. Virol. 61, 94-99 (2000).
8. Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376 (2004).
9. Gerhard, W., Yewdell, J., Frankel, M. E. & Webster, R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290, 713-717 (1981).
10. Caton, A. J., Brownlee, G. G., Yewdell, J. W. & Gerhard, W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417-427 (1982).
11. Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-360 (2010).
12. Wei, C. J. et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2, 24ra21 (2010).
13. Koel, B. F. et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976-979 (2013).
14. Webster, R. G. & Laver, W. G. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104, 139-148 (1980).
15. Fouchier, R. A. & Smith, D. J. Use of antigenic cartography in vaccine seed strain selection. Avian Dis. 54, 220-223 (2010).
16. Sandbulte, M. R. et al. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl Acad. Sci. USA 108, 20748-20753 (2011).
17. Klimov, A. I. et al. WHO recommendations for the viruses to be used in the 2012 southern hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine 30, 6461-6471 (2012).
18. Strengell, M., Ikonen, N., Ziegler, T. & Julkunen, I. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS ONE 6, e25848 (2011).
19. Weekly Epidemiological Record, Vol. 86, 457-468 (World Health Organization, 2011).
20. Guarnaccia, T. et al. Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS Pathogens 9, e1003354 (2013).
21. O'Donnell, C. D. et al. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. MBio 3, e00120 (2012).
22. Rudneva, I. et al. Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res. 166, 61-67 (2012).
23. Hensley, S. E. et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326, 734-736 (2009).
24. Sun, H. et al. Using sequence data to infer the antigenicity of influenza virus. MBio 4, e00230 (2013).
25. Bedford, T. et al. Integrating influenza antigenic dynamics with molecular evolution. eLife 3, e01914 (2014).
26. Weekly Epidemiological Record, Vol. 89, 441-456 (World Health Organization, 2014).
27. Chambers, B. S., Parkhouse, K., Ross, T. M., Alby, K. & Hensley, S. E. Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014-2015 influenza season. Cell Rep. 12, 1-6 (2015).
28. Weekly Epidemiological Record, Vol. 90, 97-108 (World Health Organization, 2015).
29. Weekly Epidemiological Record, Vol. 90, 545-559 (World Health Organization, 2015).
30. Lin, Y. P. et al. Evolution of the receptor binding properties of the influenza A (H3N2) hemagglutinin. Proc. Natl Acad. Sci. USA 109, 21474-21479 (2012).
31. Martin, J. et al. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241, 101-111 (1998).
32. Steinbruck, L., Klingen, T. R. & McHardy, A. C. Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J. Virol. 88, 12123-12132 (2014).
33. Steinbruck, L. & McHardy, A. C. Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res. 39, e4 (2011).
34. Luksza, M. & Lassig, M. A predictive fitness model for influenza. Nature 507, 57-61 (2014).
35. Neher, R. A. & Bedford, T. nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 31, 3546-3548 (2015).
36. Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345-9350 (1999).
37. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. & Perez, D. R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146, 2275-2289 (2001).
38. Xu, R., McBride, R., Nycholat, C. M., Paulson, J. C. & Wilson, I. A. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J. Virol. 86, 982-990 (2012).